Coronary Artery Bypass Graft Market Analysis

Coronary Artery Bypass Graft Market Analysis

To get key market trends

  Download Free Sample

The market is segmented into grafts, retractors, heart positioners, tissue stabilizers, and other products based on product. The grafts segment is further sub-segmented into saphenous vein grafts, internal thoracic artery grafts, and other grafts. The grafts segment was worth over USD 3.1 billion in 2023.
 

• Improvements in manufacturing techniques, including tissue engineering and 3D printing, have enabled the production of grafts that more closely resemble natural blood vessels. These advancements reduce post-surgical complications, enhance compatibility, and lower rejection rates, making coronary artery bypass grafting (CABG) more accessible and increasing demand for advanced grafts.
   
• Innovations in graft materials, such as synthetic, bioengineered, and drug-eluting grafts, are significantly improving outcomes. These new materials are more durable, biocompatible, and less prone to restenosis, reducing complications and improving patient recovery, which supports market growth.
   
• The trend toward hybrid coronary revascularization, combining CABG with percutaneous coronary intervention (PCI), is gaining prominence, particularly for complex cases. These hybrid procedures often utilize both traditional and synthetic grafts, expanding the market for grafts that accommodate these dual approaches.
   
• Therefore, the aforementioned factors are likely to sustain the demand for standard formulas in the near future.
   

Based on method, the coronary artery bypass graft market is bifurcated into traditional (on-pump) CABG and minimally invasive direct CABG. The traditional (on-pump) CABG segment dominated the market with the largest revenue share of 55.1% in 2023.
 

• The increasing global prevalence of coronary artery disease (CAD) is a key factor driving coronary artery bypass graft (CABG) procedures. Coronary heart disease (CHD) is the most prevalent form of heart disease, responsible for around 375,476 deaths annually. Additionally, approximately 805,000 people in the U.S. experience a heart attack each year, highlighting the critical need for effective treatments like traditional CABG.
   
• Additionally, sedentary lifestyles, poor dietary habits, and the rising incidence of conditions such as diabetes and hypertension contribute significantly to CAD, thereby increasing the demand for traditional CABG surgeries to enhance patient outcomes.
   
• Furthermore, traditional on-pump CABG is often the preferred choice for complex cases, particularly in multi-vessel disease scenarios where precision and control are crucial. The heart-lung machine used in on-pump CABG provides a stable, bloodless surgical field, making it advantageous for high-risk or complex patients. This factor maintains the demand for this procedure among surgeons and cardiologists.
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment over the forecast period.
   

The market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery based on surgery type. The single CABG surgery segment is projected to reach USD 7.1 billion by 2032.
 

• Single CABG offers a focused approach for patients with limited artery blockage, presenting a less invasive alternative to multi-vessel bypass surgery. The increasing adoption of minimally invasive techniques, including surgical robots, is driving demand for targeted surgical interventions in coronary artery disease treatment.
   
• The expanding elderly population is a key factor driving the single CABG market. Older individuals face a higher risk of coronary artery disease and related conditions. Single CABG is often preferred for elderly patients with isolated blockages, offering a targeted intervention with a lower risk profile.
   
• The World Health Organization reports that the global population aged 60 years and older is expected to double from 1 billion in 2020 to 2.1 billion by 2050. This demographic shift is likely to increase the demand for single CABG procedures, as they offer a balance between effective treatment and reduced surgical risk for older patients.
   
• Therefore, the aforementioned factors are expected to significantly boost the growth of the segment in the coming years.
   

The market is segmented by end use into hospitals, cardiology centers, and other end users. In 2023, the hospitals segment was valued at USD 5.3 billion.
 

• Cardiovascular disease remains a leading cause of mortality globally, maintaining high demand for CABG procedures in hospitals. According to the World Health Organization (WHO), cardiovascular diseases are responsible for 31% of all deaths worldwide. This high prevalence of cardiovascular disease underscores the continued importance of CABG procedures in hospital settings.
   
• Hospitals are equipped with advanced facilities necessary for CABG procedures, including heart-lung machines, intensive care units (ICU), and specialized operating rooms. These comprehensive facilities support safe and effective CABG surgeries, making hospitals the preferred setting for these procedures.
   
• Additionally, complex cases of multi-vessel coronary artery disease (CAD) that require surgical intervention are frequently handled in hospitals. Multi-vessel disease often necessitates a controlled environment and specialized surgical expertise found in hospital settings, wherein the precision required for successful CABG can be provided.
   

The U.S. coronary artery bypass graft market was crossed USD 3.5 billion in 2023 and is expected to grow at a CAGR of 6.7% through 2032.
 

• U.S. hospitals are increasingly adopting advanced surgical techniques for coronary artery bypass grafting (CABG), including minimally invasive and robotic-assisted procedures. These advancements reduce recovery time and post-surgical complications, making CABG a more attractive and accessible option for patients, thereby increasing its demand.
   
• The rising incidence of multi-vessel disease, where blockages occur in more than one coronary artery, is leading to increased demand for CABG in the U.S. Single-vessel interventions like percutaneous coronary intervention (PCI) may be less effective for these cases, making CABG the preferred treatment for complex coronary artery disease.
   
• According to the National Institutes of Health, approximately 400,000 CABG procedures are performed annually in the U.S. This high number of procedures reflects the continued importance of CABG in treating coronary artery disease.
   
• Therefore, the aforementioned factors are expected to boost market growth in the region over the coming years.
   

The coronary artery bypass graft market in the UK is expected to experience significant growth from 2024 to 2032.
 

• The increasing prevalence of conditions such as diabetes and hypertension in the United Kingdom is contributing to a higher risk of coronary artery disease (CAD).
   
• According to Diabetes UK, an estimated 5.6 million people in the UK are living with diabetes. Similarly, hypertension affects around 26-28% of adults in England. These rising rates are leading to an increased number of patients requiring coronary artery bypass grafting (CABG) surgery to manage heart disease complications. This trend underscores the growing importance of CABG procedures in addressing the cardiovascular health challenges faced by the UK population.
   
• The National Health Service (NHS) has prioritized reducing wait times for cardiac procedures, including CABG. Through initiatives aimed at streamlining referral pathways and improving access to timely cardiac care, more patients are undergoing CABG procedures. For instance, the NHS Long Term Plan aims to increase the number of planned operations significantly by 2023/24. This focus on accessibility and reduced wait times is driving increased demand for these surgeries, potentially leading to improved outcomes for patients with severe coronary artery disease.
   
• Hence, the increasing awareness and government programs are expected to significantly boost the market growth in the region over the coming years.
   

The Japan coronary artery bypass graft market is anticipated to witness substantial growth between 2024 – 2032.
 

• In 2023, the average life expectancy in Japan was 87.14 years for women and 81.09 years for men, ranking among the highest globally according to the World Health Organization (WHO). This longevity has led to a rapidly aging population, with 29.1% of Japanese citizens aged 65 or older in 2023, as reported by the BBC.
   
• This aging population contributes to a higher incidence of age-related cardiovascular diseases. This demographic trend increases the demand for coronary artery bypass graft (CABG) surgeries, particularly for treating coronary artery disease (CAD).
   
• Additionally, advancements in surgical techniques, including minimally invasive CABG and robotic-assisted procedures, are becoming more prevalent in Japan. These innovations enhance surgical outcomes and shorten recovery periods, making CABG a more appealing option for patients and consequently driving market growth.
   
• Therefore, the following factors are expected to bolster market growth in the region over the forecast period.
   

The coronary artery bypass graft market in Saudi Arabia is expected to experience significant growth from 2024 to 2032.
 

• The Saudi government has invested substantially in healthcare infrastructure as part of its Vision 2030 initiative. These investments aim to expand healthcare facilities and services, including specialized cardiac care units, thereby increasing the country's capacity for performing CABG surgeries.
   
• Additionally, Saudi Arabia is establishing itself as a medical tourism destination, attracting patients from neighboring countries seeking high-quality healthcare services. The availability of advanced cardiac procedures, including CABG, appeals to international patients, thus expanding the market for these surgeries within the country.
   
• Therefore, the aforementioned factors are expected to boost market growth in the region over the coming years.